January 6th 2015
System helps curb meth production in U.S.
Lutherville, MD – The National Association of Drug Diversion Investigators (NADDI) – a nonprofit
organization that facilitates cooperation between law enforcement, healthcare professionals, state
regulatory agencies and pharmaceutical manufacturers in the prevention and investigation of drug
diversion has released the 2014 National Precursor Log Exchange (NPLEx) results. NPLEx reported
results for January through December (http://www.appriss.com/nplexstats), and the report suggests
movement in the right direction for the real-time stop-sale system created by Appriss, Inc for NADDI.
The breakdown by state in the report shows the total number of boxes reported as purchased, the
total number of grams reported as purchased, the total number of boxes and grams that were blocked
based on state and federal laws, and the total number of unique individuals reported as purchasing
over-the-counter pseudoephedrine and ephedrine. These numbers indicate the laws that are being
enforced by NPLEx at the point-of-sale, in real-time, and across state lines. The states included in the
report have had legislation in place for 2 years.
NADDI Executive Director Charles Cichon states that, “These year-end statistics are very convincing,
and show just how effective NPLEx is at preventing potential meth cooks from acquiring the
ingredients to make this terrible drug. I am confident in the continued success of NPLEx as the
footprint grows, and more law enforcement officials realize the potential of the system to help curb
domestic meth production.”
Established in 1989, the National Association of Drug Diversion Investigators, Inc. (NADDI) is a unique
membership organization whose members are responsible for investigating and prosecuting
pharmaceutical drug diversion. The organization has proven to be a valuable asset to law
enforcement, the pharmaceutical industry and health regulatory personnel. NADDI’s objective is
simple: to improve the members’ ability to investigate, and prosecute, pharmaceutical drug
diversion. You can learn more about NADDI here: www.NADDI.org
Appriss provides data-driven solutions to fulfill our mission of keeping communities safe and informed.
Partnering with public safety, healthcare, and leading private and public companies to deliver solutions
that prevent fraud, mitigate risk, fight crime, ensure compliance, increase public safety and save lives.
Appriss is always backed by customer support with technical support agents in the U.S. – 24x7x365.
For more information, visit www.appriss.com.